EUVIMEDEUVIMED entdecken
Crossref

Variations of Power Priors in Time‐to‐Event Analysis With Piecewise Constant Hazards Through Baseline and Outcome Similarity Driven Bounded Weighting

Heliang Shi, Maria Kudela, Yuxi Zhao iD, Margaret Gamalo iD

Pharmaceutical Statistics · 2026

DOI: 10.1002/pst.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2026. Verfasst von Heliang Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation, Immunology, and Specialty Care Statistics Strategy, Pfizer Research and Development, Pfizer Inc., USA. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Research Design. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient recruitment in clinical trials, particularly in rare diseases or pediatric populations, remains a significant challenge. Leveraging external data to supplement trial information offers a promising solution, reducing placebo allocation, and enhancing recruitment feasibility while increasing the number of patients receiving active treatment, thus improving safety evaluations. However, the success of this method depends on the alignment of external data with target data from a population characteristics perspective and scientific translation perspective. Bayesian statistical methods, including power priors, commensurate priors, and mixture priors, facilitate the dynamic adjustment of borrowed information based on outcome data when this alignment is not perfect. Such outcome‐dependent approaches ensure robust and accurate inference by recalibrating the posterior distribution when empirical results deviate from prior assumptions. In the context of time to event analysis with piecewise constant hazards, we propose a variation of the power prior through a novel bounded weighting function, which balances population similarity and/or scientific translatability with the outcome‐based criteria. Both of these innovations address the scientific principle that underpins borrowing, the scarcity of studies on population and outcome‐dependent borrowing, and the limited literature on power priors for survival data. The practical implementation of the proposed method is demonstrated through simulations and real‐world case studies, highlighting its potential to improve the accuracy of inference in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicResearch DesignHumansBayes TheoremComputer SimulationTime FactorsData Interpretation, StatisticalModels, Statistical

Stichwörter der Autor:innen

bounded weightpiecewise constant hazardpower priortime‐to‐event

Autor:innen und Institutionen

  • Inflammation, Immunology, and Specialty Care Statistics Strategy, Pfizer Research and Development, Pfizer Inc., USA.

ORCID-Profile: Yuxi Zhao, Margaret Gamalo

Zitieren

APA

Shi, H., Kudela, M., Zhao, Y., & Gamalo, M. (2026). Variations of Power Priors in Time‐to‐Event Analysis With Piecewise Constant Hazards Through Baseline and Outcome Similarity Driven Bounded Weighting. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70136

Vancouver

Shi H, Kudela M, Zhao Y, Gamalo M. Variations of Power Priors in Time‐to‐Event Analysis With Piecewise Constant Hazards Through Baseline and Outcome Similarity Driven Bounded Weighting. Pharmaceutical Statistics. 2026. doi:10.1002/pst.70136

BibTeX
@article{Shi2026,
  author = {Shi, Heliang and Kudela, Maria and Zhao, Yuxi and Gamalo, Margaret},
  title = {Variations of Power Priors in Time‐to‐Event Analysis With Piecewise Constant Hazards Through Baseline and Outcome Similarity Driven Bounded Weighting},
  journal = {Pharmaceutical Statistics},
  year = {2026},
  doi = {10.1002/pst.70136}
}
Kostenlos starten →